Sartorius Stedim Biotech (SSB) has developed a fully integrated technology platform designed to meet the requirements of today’s upstream bioprocessing. It combines an expression system with equipment and process control for the rapid development and scale-up of robust, high-titer commercial manufacturing processes.   To overcome some of the challenges the biopharmaceutical industry faces, companies must quickly assess and then focus their efforts on the drug ca...